V. Johnston

Carboplatin dosing based on measurement of renal function--experience at the Peter MacCallum Cancer Institute.

M. Millward, D. Rischin, R. Hicks, 1996, Australian and New Zealand journal of medicine.

Management of paediatric thyroid carcinoma: recent experience with recombinant human thyroid stimulating hormone in preparation for radioiodine therapy

R. Hicks, M. Zacharin, K. Waters, 2006, Internal medicine journal.

Assessment of predictors of response and long-term survival of patients with neuroendocrine tumour treated with peptide receptor chemoradionuclide therapy (PRCRT)

R. Hicks, M. Michael, M. Hofman, 2014, European Journal of Nuclear Medicine and Molecular Imaging.

Intraperitoneal distribution imaging in ovarian cancer patients

S. Dawson, M. Quinn, R. Hicks, 2011, Internal medicine journal.

High-administered activity In-111 octreotide therapy with concomitant radiosensitizing 5FU chemotherapy for treatment of neuroendocrine tumors: preliminary experience.

R. Hicks, D. Rischin, G. Kong, 2009, Cancer biotherapy & radiopharmaceuticals.

68Ga-EDTA PET/CT Imaging and Plasma Clearance for Glomerular Filtration Rate Quantification: Comparison to Conventional 51Cr-EDTA

David Binns, Michael S. Hofman, Rodney J. Hicks, 2015, The Journal of Nuclear Medicine.

68 Ga-EDTA PET / CT Imaging and Plasma Clearance for Glomerular Filtration Rate Quantification : Comparison to Conventional 51 Cr-EDTA

S. Siva, R. Hicks, M. Hofman, 2015 .

(GFR) quantification: comparison to conventional Cr-51 EDTA

S. Siva, R. Hicks, M. Hofman, 2015 .